GENE ONLINE|News &
Opinion
Blog

2025-11-07|

Metro Systems Linked to Lower Car Usage in Study of 378 European Cities

by GOAI
Share To

A recent analysis of commuting patterns across 378 European cities reveals significant differences in the impact of public transportation systems on urban mobility. The study, conducted by researcher Rafael Prieto-Curiel from the Complexity Science Hub, highlights that metro systems play a key role in reducing car dependence among city residents. However, tram networks appear to have a less pronounced effect on shifting commuters away from private vehicle use.

The research examined extensive data to assess how various modes of public transport influence commuting behavior. Findings show that cities with established metro systems experience lower rates of car usage compared to those relying primarily on tram networks or other forms of transit. Metro systems provide faster and more efficient connections across urban areas, which may contribute to their effectiveness in encouraging residents to opt for public transport over cars. In contrast, tram networks, while still valuable for local connectivity, do not demonstrate the same level of impact on reducing reliance on private vehicles. The study underscores the varying roles different transit infrastructures play in shaping urban mobility trends across Europe.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 7, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top